| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Guidelines for the use and interpretation of assays for monitoring autophagy.
|
Autophagy
|
2012
|
20.08
|
|
2
|
Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis.
|
Neuron
|
2003
|
2.19
|
|
3
|
Regulation of neuronal survival factor MEF2D by chaperone-mediated autophagy.
|
Science
|
2009
|
2.13
|
|
4
|
Regulation of hepatic stellate cell activation and growth by transcription factor myocyte enhancer factor 2.
|
Gastroenterology
|
2004
|
1.94
|
|
5
|
Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.
|
J Neurosci
|
2006
|
1.61
|
|
6
|
ERK5 activation of MEF2-mediated gene expression plays a critical role in BDNF-promoted survival of developing but not mature cortical neurons.
|
Proc Natl Acad Sci U S A
|
2003
|
1.61
|
|
7
|
Control of MEF2 transcriptional activity by coordinated phosphorylation and sumoylation.
|
J Biol Chem
|
2005
|
1.58
|
|
8
|
Phosphorylation of ATM by Cdk5 mediates DNA damage signalling and regulates neuronal death.
|
Nat Cell Biol
|
2009
|
1.57
|
|
9
|
Alternative mitochondrial electron transfer as a novel strategy for neuroprotection.
|
J Biol Chem
|
2011
|
1.41
|
|
10
|
Cyclin-dependent kinase 5 mediates neurotoxin-induced degradation of the transcription factor myocyte enhancer factor 2.
|
J Neurosci
|
2005
|
1.40
|
|
11
|
Direct regulation of complex I by mitochondrial MEF2D is disrupted in a mouse model of Parkinson disease and in human patients.
|
J Clin Invest
|
2011
|
1.30
|
|
12
|
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.
|
Am J Pathol
|
2007
|
1.28
|
|
13
|
Cdk5-mediated regulation of the PIKE-A-Akt pathway and glioblastoma cell invasion.
|
Proc Natl Acad Sci U S A
|
2008
|
1.22
|
|
14
|
SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease.
|
Neurosci Res
|
2004
|
1.18
|
|
15
|
Activation of cyclin-dependent kinase 5 by calpains contributes to human immunodeficiency virus-induced neurotoxicity.
|
J Neurochem
|
2007
|
1.16
|
|
16
|
Calcium channel and NMDA receptor activities differentially regulate nuclear C/EBPbeta levels to control neuronal survival.
|
Neuron
|
2003
|
1.11
|
|
17
|
Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity.
|
Proc Natl Acad Sci U S A
|
2007
|
1.10
|
|
18
|
Regulation of neuroprotective activity of myocyte-enhancer factor 2 by cAMP-protein kinase A signaling pathway in neuronal survival.
|
J Biol Chem
|
2005
|
1.03
|
|
19
|
Chaperone-mediated autophagy: machinery, regulation and biological consequences.
|
Cell Mol Life Sci
|
2010
|
1.01
|
|
20
|
AKT and CDK5/p35 mediate brain-derived neurotrophic factor induction of DARPP-32 in medium size spiny neurons in vitro.
|
J Biol Chem
|
2007
|
0.99
|
|
21
|
Phosphorylation of neuronal survival factor MEF2D by glycogen synthase kinase 3beta in neuronal apoptosis.
|
J Biol Chem
|
2009
|
0.96
|
|
22
|
Essential role of cytoplasmic cdk5 and Prx2 in multiple ischemic injury models, in vivo.
|
J Neurosci
|
2009
|
0.91
|
|
23
|
Parkinson disease: a role for autophagy?
|
Neuroscientist
|
2010
|
0.90
|
|
24
|
Dysregulation of autophagy and Parkinson's disease: the MEF2D link.
|
Apoptosis
|
2010
|
0.85
|
|
25
|
Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins.
|
Neurotoxicology
|
2011
|
0.84
|
|
26
|
Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.
|
J Biol Chem
|
2012
|
0.83
|
|
27
|
Oxidation of survival factor MEF2D in neuronal death and Parkinson's disease.
|
Antioxid Redox Signal
|
2014
|
0.83
|
|
28
|
Activity deprivation-dependent induction of the proapoptotic BH3-only protein Bim is independent of JNK/c-Jun activation during apoptosis in cerebellar granule neurons.
|
Neurosci Lett
|
2004
|
0.81
|
|
29
|
Calpain-mediated degradation of myocyte enhancer factor 2D contributes to excitotoxicity by activation of extrasynaptic N-methyl-D-aspartate receptors.
|
J Biol Chem
|
2012
|
0.80
|
|
30
|
Cdk5: mediator of neuronal development, death and the response to DNA damage.
|
Mech Ageing Dev
|
2011
|
0.80
|
|
31
|
Neurotoxin-induced selective ubiquitination and regulation of MEF2A isoform in neuronal stress response.
|
J Neurochem
|
2012
|
0.79
|
|
32
|
JNK inhibition as a potential strategy in treating Parkinson's disease.
|
Drug News Perspect
|
2004
|
0.78
|
|
33
|
Chaperone-mediated autophagy and neurodegeneration: connections, mechanisms, and therapeutic implications.
|
Neurosci Bull
|
2015
|
0.77
|
|
34
|
Regulation of MEF2s by chaperone-mediated autophagy.
|
Cell Cycle
|
2009
|
0.77
|
|
35
|
Perturbation of transcription factor Nur77 expression mediated by myocyte enhancer factor 2D (MEF2D) regulates dopaminergic neuron loss in response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
|
J Biol Chem
|
2013
|
0.77
|
|
36
|
Modulation of Neuronal Survival Factor MEF2 by Kinases in Parkinson's Disease.
|
Front Physiol
|
2012
|
0.77
|
|
37
|
The complexity in regulation of MEF2D by chaperone-mediated autophagy.
|
Autophagy
|
2009
|
0.76
|
|
38
|
Indirubin-3'-oxime inhibits c-Jun NH2-terminal kinase: anti-apoptotic effect in cerebellar granule neurons.
|
Neurosci Lett
|
2004
|
0.76
|
|
39
|
Regulation of MEF2s by chaperone-mediated autophagy.
|
Cell Cycle
|
2009
|
0.75
|